Dasatinib 59651-0546
Product NDC
59651-0546- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 22, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA216547
Need to source Dasatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dasatinib | 100 mg/1 |
Drug Class
Cytochrome P450 3A4 Inhibitors [MoA]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(2)
1 BLISTER PACK in 1 CARTON (59651-546-15) / 15 TABLET in 1 BLISTER PACK
30 TABLET in 1 BOTTLE (59651-546-30)